According to The Business Research Company’s research report on the dialysis devices and equipment market, the rising prevalence of chronic diseases such as diabetes and hypertension is expected to be a major driver of the dialysis equipment market. These chronic illnesses frequently precede the onset Monolayer Graphene Films are the subject of intense scientific research due to their unique electronic properties and have potential applications in microelectronics applications micro- and nano-electromechanical systems (MEMS and NEMS), in field effect transistors (FETs), and in chemical and biological sensors among others. The global Monolayer Graphene Film market is valued at US$ xx million … Growth forecasts, trade wars and stimulus hopes are likely a more direct driver for the Dollar with the WTO’s Boeing ruling a particular EURUSD measure China’s trade picked up in September as exporters benefited from the country’s relatively early reopening from pandemic shutdowns and strong global demand for masks and medical supplies The definitive collection of the best investing stories Business Insider published during the week ended October 13. U.S. stock markets closed sharply higher on Monday supported by strong performance of large-cap technology stocks.
According to The Business Research Company’s research report on the dialysis devices and equipment market, the rising prevalence of chronic diseases such as diabetes and hypertension is expected to be a major driver of the dialysis equipment market. These chronic illnesses frequently precede the onset of the chronic kidney failure. According to the United Nations, the proportion of total global deaths due to chronic diseases is expected to increase to 70% and the global burden of chronic diseases is expected to reach about 60% by 2030. Extended working hours, limited physical activity, and unhealthy food habits are the major causes of chronic diseases such as diabetes. This will increase the demand for medical devices used in diagnosis, and treatment of chronic kidney diseases, driving the dialysis devices market.
London, Oct. 13, 2020 (GLOBE NEWSWIRE) — (Dialysis Devices And Equipment Companies Included: Fresenius Medical Care AG & Co. KGaA, Baxter International, Nikkiso Co. Ltd, DaVita Inc., B. Braun Avitum AG, NxStage Medical, Asahi Kasei Corporation, Diaverum Deutschland GmbH, MEDIVATORS Inc., Nipro Corporation, Allmed Medical Corp, Gambro, TORAY MEDICAL CO. LTD, Teleflex Incorporated, US Renal Care, Bellco S.R.L., C. R. Bard Inc., CVS Health, Cigna, Dialife S.A., Medtronic Inc., Hemoclean Co. Ltd., Humacyte, Rockwell Medical Inc., TVA Medical Inc.)
The global dialysis equipment market size reached a value of nearly $16.53 billion in 2019, having increased at a compound annual growth rate (CAGR) of 3.1% since 2015. The market is expected to decline from $16.53 billion in 2019 to $13.29 billion in 2020 at a rate of -19.6%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 8.7% from 2021 and reach $19.59 billion in 2023. The market is expected to reach $21.94 billion in 2025, and $29.01 billion in 2030.
Faster growth in the forecast period than in the historic period can be attributed to the increasing prevalence of chronic diseases, leading to an increase in per capita healthcare expenditure, increasing home therapies, rise in technological advancements and increasing number of end-stage renal diseases. Demand for dialysis equipment, development of healthcare sector in emerging countries such as India and China, government initiatives towards providing free healthcare insurance policies and relaxation in government regulations all add to the growth of the market.
The Business Research Company’s report titled Dialysis Devices And Equipment Global Market Report 2020-30: COVID 19 Impact and Recovery covers major dialysis devices and equipment companies, dialysis devices and equipment market share by company, dialysis devices and equipment manufacturers, dialysis devices and equipment market size, and dialysis devices and equipment market forecasts. The report also covers the global dialysis devices and equipment market and its segments. The dialysis devices and equipment market is segmented by product: hemodialysis devices, peritoneal dialysis devices, by end-user: hospitals, clinics, ambulatory surgical centers, home care settings.
Request For A Sample Of The Global Dialysis Devices And Equipment Market Report:
With the COVID-19 outbreak, since the coronavirus can be easily spread to humans through direct human-to-human contact or indirect surface-to-human contact, the trends in the dialysis devices and equipment market reflect accordingly. One such trend has been to use disposable consumable products which can be thrown away after a single use. Many companies are investing in manufacturing and selling disposable items such as caps, blood tubes, AV fistula needles, dialysis catheters, dialysis membranes and other dialysis consumables as they limit the spread of the virus and reduce the risk of infection.
Along with this, the preference for home therapies is increasing due to its flexible treatment options, reduction in costs and fear over the ongoing pandemic. According to the many evidences, COVID-19 causes serious immunity problems in the most severely ill patients. The studies also suggest that the COVID-19 infection causes acute kidney injury (AKI). People on dialysis need to visit clinics or hospitals 2-3 times per week, where patients fear they can get infected by the coronavirus. The need to diagnose, treat and monitor patients without human contact has risen to contain the spread of COVID-19, resulting in increased preference for home dialysis among patients. In July 2020, the US Federal government announced increasing Medicare reimbursement rates for home dialysis machines to encourage use of home dialysis. Companies such as NxStage Medical, Inc. and Outset Medical Inc. are engaged in the development of portable hemodialysis systems.
Dialysis Devices And Equipment Global Market Report 2020-30: COVID 19 Impact and Recovery is one of a series of new reports from The Business Research Company that provide market overviews, analyze and forecast market size and growth for the whole market, dialysis devices and equipment manufacturers segments and geographies, dialysis devices and equipment manufacturers trends, dialysis devices drivers, restraints, leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies. The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports By The Business Research Company:
Nephrology And Urology Devices Global Market Report 2020-30: COVID 19 Impact and Recovery
Kidney Cancer Drugs Global Market Report 2020-30: COVID 19 Impact and Recovery
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
CONTACT: The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: firstname.lastname@example.org Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company Follow us on Twitter: https://twitter.com/tbrc_info
Author: The Business Research Company
Global Monolayer Graphene Film Market Report: Production, Revenue, Price Trend by Types & Market Analysis by Application
Monolayer Graphene Films are the subject of intense scientific research due to their unique electronic properties and have potential applications in microelectronics applications micro- and nano-electromechanical systems (MEMS and NEMS), in field effect transistors (FETs), and in chemical and biological sensors among others.
The global Monolayer Graphene Film market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
Access more details about this report at: https://www.themarketreports.com/report/global-monolayer-graphene-film-market-research-report
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and also about each type from 2015 to 2026. This section mentions the volume of production by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
The major players in the market include ACS Material, Nanografi, ChemStuk, Deluxe Family, Chongqing Graphene Technology, Nanjing MKNANO Tec, etc.
Purchase this exclusive research report at: https://www.themarketreports.com/report/buy-now/1533944
Global Monolayer Graphene Film Market: Regional Analysis
The report offers in-depth assessment of the growth and other aspects of the Monolayer Graphene Film market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Monolayer Graphene Film Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.
Inquire for more details / sample / customization about this report at: https://www.themarketreports.com/report/ask-your-query/1533944
Nasdaq Holds, S&P 500 Drops and Dollar Rallies: Stimulus, GDP and Trade Wars
Nasdaq 100, S&P 500 and Dollar Talking Points:
- Stimulus expectations around the US were once again a top headline theme, but no serious movement was found for an economy starting to flag
- The Nasdaq 100 and S&P 500 struggled this past session which led headlines to latch on to J&J vaccine delays, but is that an earnest driver?
- Growth forecasts, trade wars and stimulus hopes are likely a more direct driver for the Dollar with the WTO’s Boeing ruling a particular EURUSD measure
This week opened to an extraordinary swell in risk-leaning assets with benchmarks like the US indices charging towards record highs between a sharp bullish gap and subsequent follow through. Yet, with a record high in easy reach for the likes of the S&P 500, the drive seemed to falter. This past session, ‘risk appetite’ risk appetite faltered from US indices to emerging markets to carry trade. For traders with a baseline view bullish or bearish on sentiment trends, it is a comfort to discern a reasoning for a move against assumptions. It wasn’t difficult to suss out a bullish attachment to expectations for fiscal stimulus sometime in the foreseeable future while the bearish swoon was neatly attached to the pause in the Johnson & Johnson Covid-19 vaccine trial owing to an unexplained illness as a possible side effect. Are these really the engine behind shifting market confidence or simply a convenient justification for those unwilling to entertain a more ambiguous backdrop whereby markets really aren’t committed to a bearing nor a prime driver?
Chart of S&P 500 with 50, 100-Day Moving Averages, Gaps and 1-Day Range (Daily)
Chart Created on Tradingview Platform
I am of the mind that there isn’t a firm footing behind risk appetite – whether bullish or bearish. Trends are proving unproductive particularly when correlation is evaluated. Further, neither breaks nor reversals seem to inspire nascent interest to crush in on supposed opportunities. This is more often the habit of a market that is uncommitted in trend but suffering from unbridled volatility. There is a range of systemic risk that can be entertained in these markets from vaccines to stimulus potential to trade war fodder to V-shaped recovery risks among other issues. With such a kaleidoscope backdrop, the frequent shift in priority and sometimes abrupt instances of volatility seem to fit. In this kind of environment, retail traders’ natural inclination to fight prevailing trends tends to better fit the mold – as opposed to seeking momentum that struggles to gain traction. Retail CFD trading as measured by IG is steadily building a bias towards a heavy short position on the S&P 500.
Chart of S&P 500 with IG Speculative Positioning (4 Hour)
Chart Created on Tradingview Platform
Taking a closer look at the habits of pure speculative interests, I would note that the S&P 500 as a benchmark for traders’ interests is outpacing many global counterparts – few counterparts can claim to be just on the cusp of their own record high. Yet, even within US equities, there is a notable concentration in performance for tech shares. With the Apple event and Amazon Prime shopping ‘holiday’, there is a basis in drive yesterday and today. Both consumer events will be an interesting signal for consumer health in this period of pandemic-led economic uncertainty, but in the meantime, it has charged the Nasdaq 100’s performance even relative to the SPX. The ratio between the two has surged and loiters just off a record high. This registers as an impulsive bid for momentum rather than ‘value’. Keep close tabs on the performance of this concentrated benchmark.
Chart of Nasdaq to S&P 500 Ratio with 100-Day Moving Average (Daily)
Chart Created on Tradingview Platform
In the ultimate results from my poll last week, the number one market-moving potential theme this week is the ongoing negotiations for a US fiscal stimulus. Indeed, the anticipation for what could be on government support carried the market’s imagination through the very start of the week. However, the likelihood of a compromise seems still fairly low given the political stratagems perceived from both sides of the aisle and the White House. That will draw this situation out with little satisfaction for a definitive approval or delay. Meanwhile, the contrast of a definitive growth forecast from the IMF seems to draw limited affect – whether from the upgraded 2020 forecast or the warning of the recovery’s fragility.
Twitter Poll on Most Market Moving Theme Next Week
Poll from Twitter.com, @JohnKicklighter
On the systemic fundamental side, the IMF’s WEO (World Economic Outlook) update offered a tangible upgrade to the – admittedly still-steep recession – global forecast for 2020 from -4.9 to -4.4 percent. However the 0.2 percent point downgrade to the 2021 forecast and stark warning against the robustness of the recovery and financial market stability would urge critical thinking. Meanwhile, the potential for stimulus offers soothing ambiguity. In the US, search interest in ‘stimulus hope’ outpaced its peak in April when the government was actually drafting the CARES act in response to the pandemic.
Google Trend Search Ranking for ‘Stimulus Hopes’ in United States
Chart from Google Trends
If I am to believe that stimulus is indeed such a critical market-moving potential moving forward, it is worth assessing where its potency is greatest. I am dubious the US indices are a well of untapped bounty. Just off of record highs with a ‘premium’ to other categories of risk assets and against a questionable economic backdrop, it would seem that there is some measure of saturation in risk appetite. If stimulus does eventually find the write off of the US government it seems there is more discount to work off with the Dollar than there is the Dow. Meanwhile, EURUSD – the world’s most liquid currency cross – will also have trade wars considerations to factor in.
The upcoming Presidential election can materially exacerbate trade wars already eroding growth.Read this article to see analysis on the expected impact of the election outcome on trade.
Chart of EURUSD with 50-Day Moving Averages, 1-Day ROC and 10-Day Range (Daily)
Chart Created on Tradingview Platform
As of this past session, the WTO announced that European authorities could pursue $4 billion in damages against the United States for illegal subsidies to Boeing. It is worth noting that this group gave the US the green light to seek restitution of up to $7.5 billion against Europe for Airbus support. Given the enthusiasm for which the US pursued the import taxes, it is unlikely that Europe takes ‘the high road’. Meanwhile trade will also take on a new risk in unresolved digital taxes while the US-China trade war continues to wear on. If anything this relationship is unlikely to go back to ‘normal’ regardless of the next administration. China recognizes this and seems to be making a valiant effort to shift dependency to domestic sources. Is the market confident they will get there?
Chart of USDCNH with 50-Day Moving Averages with SPX-Shanghai Composite Ratio (Daily)
Chart Created on Tradingview Platform
If you want to download my Manic-Crisis calendar, you can find the updated file here.
Author: John Kicklighter
China’s trade growth accelerates in Sept; exports up 9.9%
China’s trade picked up in September as exporters benefited from the country’s relatively early reopening from pandemic shutdowns and strong global demand for masks and medical supplies
BEIJING — China’s trade picked up in September as global demand for masks and medical supplies boosted exports and the economy’s early reopening gave producers an edge over foreign competitors.
Exports rose 9.9% over a year earlier to $239.8 billion, up from August’s 9.5%, the fourth straight month of growth, customs data showed Tuesday. Imports gained 13.2% to $202.8 billion, up from the previous month’s 2.1% contraction as the world’s second-largest economy regained momentum.
Exports had a “comprehensive recovery” in the three months ending in September, said a spokesman for the customs agency, Li Kuiwen. He said China has exported masks and other medical supplies worth 1 trillion yuan ($150 billion).
China has “successfully filled the global supply shortage,” Li said at a news conference.
Chinese exporters have benefited from relative early end of travel and trade curbs after the ruling Communist Party declared victory over the outbreak in March. They are taking market share from foreign competitors that are hampered by anti-disease controls.
“Renewed virus outbreaks in trading partners will be a challenge, but shipments of products benefiting from virus-related demand should continue to hold up,” Louis Kuijs of Oxford Economics said in a report.
China’s global trade surplus swelled 6.6% over a year earlier to $37 billion but was down sharply from August’s $58.9 billion gap, thanks to higher exports.
Exports to the United States rose 20.5% over a year ago to $44 billion despite higher U.S. tariffs in a fight with the Trump administration over Beijing’s technology ambitions and trade surplus. Imports of American goods rose 24.5% to $13.2 billion.
China became the first major economy to rebound to pre-virus growth levels in the second quarter of the year, when the government reported 3.2% economic growth over a year earlier. Forecasters expect that to accelerate in the three months that ended in September.
Automakers and other large manufacturers are back to normal activity, helping to drive demand for imported iron ore, copper and other industrial materials.
Importers are meanwhile benefitting from a slump in prices of oil and other commodities due to weak demand.
Retail sales remain subdued as consumers who are uneasy about possible job losses put off major purchases. Consumer spending returned to pre-virus levels in August but was only 0.5% above a year earlier.
Economists have warned some Chinese exporters of smartphones and other high-tech goods might face trouble due to restrictions imposed by Washington on their access to U.S. components on security grounds.
Washington has cut off supplies of components for companies including China’s most prominent tech brand, Huawei Technologies Ltd.
The Trump administration is lobbying European and other allies to avoid Chinese suppliers as they upgrade to next-generation telecom networks. That could weigh on exports of technology products Beijing is promoting to propel economic development.
Author: ABC News
Capitalizing on volatility — Inside SPAC mania — 13 proven trading rules
If you’ve noticed more pronounced price swings in the market lately, that’s not just your mind playing tricks on you. After years upon years of relaxed trading, stocks have been jolted out of their slumber.
The volatility is a natural byproduct of the COVID-19 pandemic and everything associated with it: a record-shattering economic pullback and sharp recovery, emergency central bank actions, the race for a working vaccine, and assorted political machinations befitting an election year — most notably talks around a new stimulus package.
Complicating matters further is that each of the four factors listed above is capable of moving the market on a given day. That’s why the Investing team at Business Insider has been on the hunt for guidance from the world’s top experts.
At the forefront of our research has been what happens in different stimulus scenarios. To that end, one CIO has made it simple and pinpointed the sectors poised to outperform even if a bill isn’t passed until after the election.
We’ve also spoken to fund managers who are racing to capitalize on market upheaval. One expert who’s adjusting to the new normal of elevated volatility recently offered both strategies poised to outperform, and also single stocks he’s buying himself. Another stock-picker we interviewed is scouring downtrodden stocks for hidden gems — and broke down three bets he’s making.
Meanwhile, Citi’s US stock chief is eyeing the upcoming earnings season as the next driver of volatility. He thinks an “unstable” number of companies have bumped guidance higher, which could lead to near-term selling.
For more, see below Business Insider’s best Investing stories of the week, which include a wide array of additional recommendations, strategies, and tips for navigating uncertainty.
Thanks for reading!
Join Business Insider on Wednesday, October 21 at 2 p.m. ET and hear from three investment experts who will share their advice on how to navigate the election-season peak.
Topics will include: investing strategies for protecting your portfolio regardless of who wins the election, the individual sectors and stocks poised to benefit from distinct outcomes, and advice on how to navigate a contested result.
Jerome Myers, the founder of The Myers Development Group and host of the “Multifamily Missteps” podcast, realized the power of real-estate investing after conducting a back-of-the-napkin calculation on the steps of his apartment complex.
After being rejected by loads of banks, Myers started fixing and flipping properties with a hard-money lender. When he acquired a business partner, Myers went full bore into multifamily apartment investing, leveraging a four-part strategy.
Read the full story here:
US SPACs have raised $39 billion year-to-date and accounted for one-third of all US IPO activity since the start of 2019, according to Goldman Sachs Global Investment Research. The frenzy reached the ETF industry when the first US SPAC ETF — the Defiance Next Gen SPAC Derived ETF — started trading on October 1.
Paul Dellaquila, president of Defiance ETFs, breaks down why he believes a SPAC ETF can provide retail investors with access to IPOs once reserved only for institutional and high-net-worth investors.
Read the full story here:
Richard Dennis, a legendary commodities trader profiled in Jack Schwager’s classic “Market Wizards” series, got his start in trading by borrowing $1,600 from family. After a sizable loss, Dennis revisited his strategy, which he said was unrefined. He then stumbled upon a trend-following approach and stuck with it.
According to Schwager, he eventually turned that initial $1,600 capital injection into an estimated $200 million. Dennis shared with Schwager 13 trading rules that contributed to his success.
Read the full story here:
Seeking experts who are willing to name names? Look no further:
- GOLDMAN SACHS: Buy these 25 stocks expected to generate the greatest returns on their shareholders’ investments over the next year as market-wide earnings remain low
- These 30 global stocks are positioned to stay on top in the 4th quarter as the contrast between a recovering economy and rising COVID cases keeps markets volatile, RBC says
- The space industry will grow by over $1 trillion in the next decade, says Bank of America. Here are the 14 stocks best-positioned to benefit from the boom.
- Buy these 15 stocks set to deliver the strongest possible profit growth and subsequent returns through year-end, Goldman Sachs says
- Barclays shares 7 UK stocks to buy with positive catalysts in the 4th quarter — and the 2 stocks to avoid at all costs
- Buy these 7 stocks poised to profit from the boom in packaged-food sales as COVID-19 prompts more Americans to cook at home, Stifel says
- Goldman Sachs says to buy these 21 stocks poised to deliver the strongest sales growth through year-end
The chart above offers evidence that cries of an overvalued tech sector are overblown.
It shows that although tech companies currently makes up a historically large portion of the benchmark S&P 500, they’re also contributing more earnings than they were when the dot-com bubble burst. That suggests they’re not as vulnerable — and may even be living up to their enormous size.
“Investment banks, underwriters and high-net-worth people like Warren Buffett get to participate in hot IPOs like Snowflake and they got in at $120 a share. However, mom-and-pop investors and the average Joe got access to Snowflake at $240 a share and that’s just on the first day. So it doesn’t leave a lot of meat on the bones for individual investors to pay almost 100% premium on what high-net-worth investors got.”
— Paul Dellaquila, president of Defiance ETFs, outlining the disconnect at the heart of his firm’s recent fund launch, which aims to get retail investors in on hot SPACs
Author: Joe Ciolli
Stock Market News for Oct 13, 2020
U.S. stock markets closed sharply higher on Monday supported by strong performance of large-cap technology stocks. Moreover, market participants are gearing up for the third-quarter earnings season that will start this week. All the three major stock indexes ended in positive territory.
The Dow Jones Industrial Average (DJI) gained 0.9% or 250.62 points to close at 28,837.52, maintaining 4-day winning streak. Notably, 23 components of the 30-stock index ended in the green while 5 finished in red and 2 remained unchanged.
Moreover, the tech-laden Nasdaq Composite finished at 11,876.26, surging 2.6% or 296.32 points due to the strong performance by large-cap technology stocks. The tech-heavy index has gained for four successive days. This was the index’s best single-day performance since Sep 9.
Meanwhile, the S&P 500 advanced 1.6% to end at 3,534.22, continuing 4-day winning run. The Communication Services Select Sector SPDR (XLC) and the Technology Select Sector SPDR (XLK) advanced 2.6% and 2.7%, respectively. Notably, ten out of eleven sectors of the benchmark index closed in positive zone and one in the red.
The fear-gauge CBOE Volatility Index (VIX) was up 0.7% to 25.07. A total of 8.2 billion shares were traded on Monday, lower than the last 20-session average of 9.7 billion. Advancers outnumbered decliners on the NYSE by a 1.79-to-1 ratio. On Nasdaq, a 1.57-to-1 ratio favored advancing issues.
The technology sector played the lead role for market’s strong rally yesterday. Apple Inc. (AAPL – Free Report) climbed 6.4%, marking its best daily gain since Jul 31. The company is set to launch a 5G iPhone on Oct 13. Moreover, Amazon.com Inc. (AMZN – Free Report) advanced 4.8% and investors are waiting for the company’s Prime Day shopping event on Oct 13 and 14.
Moreover, Facebook Inc. (FB – Free Report) , Alphabet Inc. (GOOGL – Free Report) and Microsoft Corp. (MSFT – Free Report) rallied 4.3%, 3.6% and 2.6%, respectively. Each of these stocks carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Notably, last year, which recorded the best performance of Wall Street in six years, technology stocks drove the overall market. This year, which witnessed an unprecedented health-hazard-led massive economic devastations, again the technology sector is leading the recovery.
Despite negative expectations for the third-quarter earnings results, the important fact is that the overall projections have gradually improved since July, on the reopening of a large part of the U.S. economy. The U.S. economy is notably growing, albeit at a slow pace, despite the lack of a second round of fiscal stimulus. This should sustain the improving earnings trend.
BP Kick-Starts Ghazeer Gas Production Ahead of Schedule
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot stocks we’re targeting >>
Author: Zacks Investment Research